GenBio AI
PrivateLast Round
Series A
Jun 24, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GenBio AI operates in Healthcare & Life Sciences and is based in Palo Alto, California. It was founded in 2024.
GenBio AI is a biotechnology company that develops AI-driven multiscale foundation models to simulate, predict, and program biological systems for drug discovery and biomedical research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenBio AI Comparables
Compare GenBio AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noetik | 86% | |
| CellType | 85% | |
| Rivercell | 83% |
For institutional investors. Book with your work email.
GenBio AI Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 70% MoM.
- Jul 22, 2026
Grew 28% QoQ, from 53 to 68 employees.
For institutional investors. Book with your work email.
GenBio AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenBio AI's valuation, stock price, and market status.
Is GenBio AI a public or private company?
GenBio AI is a private company.
What is the current stock price of GenBio AI?
GenBio AI is a private company, so its shares have no public market price. Caplight tracks GenBio AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenBio AI worth (valuation)?
Valuation information for GenBio AI is not publicly available.
Can I buy GenBio AI stock?
GenBio AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenBio AI's last funding round?
GenBio AI's most recent funding round was Series A on June 24, 2026.
Who are the main investors in GenBio AI?
Investor information for GenBio AI is not publicly disclosed.
Will GenBio AI IPO soon?
No public IPO plans have been announced for GenBio AI.
How can I track GenBio AI secondary market activity?
Caplight tracks bids, offers, and trades in GenBio AI's shares on secondary markets.